Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

(University of Oxford) * High-level vaccine efficacy of 77% in African children achieve WHO-specified efficacy goal of 75%* Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated* Vaccine candidate, R21/Matrix-M, has excellent potential for large-scale manufacturing and low-cost supply